Therapeutic Targeting of DGKA-Mediated Macropinocytosis Leads to Phospholipid Reprogramming in Tuberous Sclerosis Complex

MLA

Hilaire C. Lam, et al. “Therapeutic Targeting of DGKA-Mediated Macropinocytosis Leads to Phospholipid Reprogramming in Tuberous Sclerosis Complex.” Cancer Research, vol. 81, Feb. 2021, pp. 2086–100. EBSCOhost, https://doi.org/10.1158/0008-5472.can-20-2218.

APA

Hilaire C. Lam, Long Zhang, Elizabeth P. Henske, Thomas Hougard, Clemens K. Probst, Harilaos Filippakis, Kosmas Kosmas, Ryan Rue, David J. Kwiatkowski, Vera P. Krymskaya, Andres Sanin, Elie W. Akl, Ji Wang, Andrii Kovalenko, Krinio Giannikou, & John M. Asara. (2021). Therapeutic Targeting of DGKA-Mediated Macropinocytosis Leads to Phospholipid Reprogramming in Tuberous Sclerosis Complex. Cancer Research, 81, 2086–2100. https://doi.org/10.1158/0008-5472.can-20-2218

Chicago

Hilaire C. Lam, Long Zhang, Elizabeth P. Henske, Thomas Hougard, Clemens K. Probst, Harilaos Filippakis, Kosmas Kosmas, et al. 2021. “Therapeutic Targeting of DGKA-Mediated Macropinocytosis Leads to Phospholipid Reprogramming in Tuberous Sclerosis Complex.” Cancer Research 81 (February): 2086–2100. doi:10.1158/0008-5472.can-20-2218.